|
Volumn 302, Issue 15, 2009, Pages 1645-
|
Lipoprotein(a) measurement and determining risk of myocardial infarction
|
Author keywords
[No Author keywords available]
|
Indexed keywords
APOLIPOPROTEIN B;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPOPROTEIN A;
NICOTINIC ACID;
ANTILIPEMIC AGENT;
CARDIOVASCULAR RISK;
HEART INFARCTION;
HUMAN;
LETTER;
LIPOPROTEIN BLOOD LEVEL;
MEDICAL DECISION MAKING;
PRIORITY JOURNAL;
RISK ASSESSMENT;
BLOOD;
CHEMISTRY;
KRINGLE DOMAIN;
NOTE;
RISK;
ANTILIPEMIC AGENTS;
HUMANS;
KRINGLES;
LIPOPROTEIN(A);
MYOCARDIAL INFARCTION;
RISK;
|
EID: 70350721736
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2009.1483 Document Type: Letter |
Times cited : (2)
|
References (4)
|